Archean Chemical Industries Ltd
NSE:ACI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Archean Chemical Industries Ltd
NSE:ACI
|
IN |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
B
|
Banca Mediolanum SpA
OTC:BNMDF
|
IT |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
Biofrontera Inc
NASDAQ:BFRI
|
US |
|
Marksans Pharma Ltd
NSE:MARKSANS
|
IN |
Wall St Price Targets
ACI Price Targets Summary
Archean Chemical Industries Ltd
According to Wall Street analysts, the average 1-year price target for ACI is 580.64 INR with a low forecast of 508.03 INR and a high forecast of 708.75 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ACI's stock price target?
Price Target
580.64
INR
According to Wall Street analysts, the average 1-year price target for ACI is 580.64 INR with a low forecast of 508.03 INR and a high forecast of 708.75 INR.
What is the Revenue forecast for Archean Chemical Industries Ltd?
Projected CAGR
18%
Over the last 3 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 4 years is 18%.
What is the Operating Income forecast for Archean Chemical Industries Ltd?
Projected CAGR
27%
Over the last 3 years, the compound annual growth rate for Operating Income has been -16%. The projected CAGR for the next 4 years is 27%.
What is the Net Income forecast for Archean Chemical Industries Ltd?
Projected CAGR
30%
Over the last 3 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 4 years is 30%.
